Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Sol-Gel Nose-to-Brain Delivery System of Cannabinoids

Universally-patient friendly, meaning formulations that can be used in children and adults alike
Transport of drugs through blood-brain barrier marks top priority for researchers
North American legal cannabis market projected at more than $24 billion by 2021
Global market for pain management, drugs and devices estimated at over $61 billion by 2023

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is a Vancouver-based health sciences company dedicated to research and development of innovative, organic and Nature Identical™ options for preventive and curative therapies for a wide array of devastating medical conditions. Developing what the company believes will be the first U.S. Food and Drug Administration-approved cannabidiol (CBD)-soluble gel product to deliver the therapeutic benefits of CBD directly to the central nervous system (CNS) is a top priority for PreveCeutical Chief Researcher Officer Dr. Harry Parekh, who is based at the University of Queensland, Australia, School of Pharmacy (http://cnw.fm/0r9U3).

Breaking through the blood-brain barrier, which functions as the last line of defense for the body’s most vital organ, is a prime research target, as noted in a May 2017 article published by The Pharmaceutical Journal (http://cnw.fm/Ru6sJ). Delivering life-saving drugs directly to the brain to treat complex brain disorders such as Alzheimer’s, Parkinson’s, epilepsy and depression in a safe and effective manner continues to be a major topic of discussion and compelling research around the world (http://cnw.fm/kLBT0). The need for a solution, a way to present a medication directly where it will do the most good with the fewest side effects, is a key driver for Dr. Parekh and his research collaborators as they continue their work on cannabinoids, formulating them into Sol-gels for further testing.

PreveCeutical’s proprietary Sol-gel formulations begin as a liquid that is administrated into the nose, which then forms a gel as it is warmed in the nasal cavity where it can then be absorbed. This effectively bypasses the stomach and intestines – eliminating first pass metabolism – and may dramatically improve bioavailability, even compared to nasal sprays and newer delivery systems. This nose-to-brain delivery method offers numerous benefits, including fewer side effects and avoidance of unwanted rapid metabolism.

“This feature can potentially be exploited to deliver drugs through the nasal mucosa,” Dr. Parekh stated in a news release. “The longer-term goal is to develop Sol-gels as safe, reliable delivery systems for cannabinoid extracts across a range of disease indications.”

PreveCeutical’s Sol-gel CBD-based technology could provide a clinical benefit for patients seeking relief for any number of medical indications, such as pain, inflammation, seizures and neurological disorders. In addition to its ease of application, a CBD-based Sol-gel will stay in the nasal passages longer, slowly releasing the CBD while keeping it active for up to seven days.

The legal cannabis market, which includes CBD-based therapy, is projected to reach $24 billion by 2025, according to a report published in Hemp Business Journal (http://cnw.fm/qA7WO), with an overwhelming number of those surveyed stating that CBD therapy was being used for depression or pain. An analysis by Stratistics MRC also shows that the global pain management, drugs and devices market is expected to reach $61.52 billion by 2023 as the population ages and improving health care technologies and alternative therapies attract more attention (http://cnw.fm/AWc0e).

For more information, visit the company’s website at www.PreveCeutical.com

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

The Modern Cannabis Industry — A Tight Mesh of Integrated Verticals and Technologies

CannabisNewsWire Editorial Coverage: The number of adults in America who want marijuana legalized has nearly doubled since 2000, according to the latest Pew Research Center survey, which indicates 61 percent are now in favor (http://cnw.fm/1CdYE). During that same interval, the industry has evolved from a taboo underground into a clean and professional marketplace. Now the cannabis industry is on track to outpace the manufacturing sector in terms of job creation by 2020 (http://cnw.fm/ae5YX). The multiple, increasingly interwoven verticals now present in this booming industry run the gamut. However, payment solutions, such as those offered by Global Payout, Inc. (OTC: GOHE) (GOHE Profile), represent some of the most high-potential integrations. Other key verticals here, such as digital advertising and marketing from companies such as mCig, Inc. (OTCQB: MCIG), or the news, print and digital multimedia offerings of Freedom Leaf, Inc. (OTCQB: FRLF), further underscore how developed the sector has become. This is true even before one considers verticals like the packaging, branding and compliance solutions provided by companies such as Kush Bottles, Inc. (OTCQB: KSHB), or the hydroponic and indoor growing systems developed by Solis Tek, Inc. (OTCQB: SLTK).

Strategic Partnerships Detail Diversity

The numerous strategic partnerships developed by Global Payout, Inc.’s (OTC: GOHE) majority-owned subsidiary MoneyTrac Technology, Inc. (“MTRAC”) in recent months brilliantly reveal the intersect potential of cannabis, finance, compliance and banking. Moreover, with the completion of the requisite due diligence and final steps needed for a Regulation D, Rule 506(c) security offering, MTRAC is now poised to offer the cash-driven cannabis industry a helping hand via the launch of its MTRAC-Token (http://cnw.fm/Jf5Ra). Because the federal government’s regulations discourage banks from handling the proceeds of marijuana transactions, thousands of profitable businesses, often doing hundreds of thousands of dollars a month in sales legalized by their respective states, have had to risk managing day-to-day operations entirely in cash (http://cnw.fm/0ZTzc).

Cannabis Goes Crypto Cashless

By harnessing the power of blockchain technology, MTRAC-Token will offer the cannabis industry a cryptocurrency-based and decentralized non-cash payment system that lends itself to regulatory compliance. The company has even tapped full-service blockchain technology and token accelerator Pegasus Fintech, Inc., to assist in ensuring that accredited investors hop on board. Investors who may have otherwise shied away from financially backing the cannabis industry will subsequently get a unique opportunity to access the 15 to 26 percent CAGR leading analysts have projected for this sector over the next several years (http://cnw.fm/9wngD). Worth nearly $8 billion already (http://cnw.fm/r8H8c), the North American cannabis industry is still woefully underserved when it comes to basic but essential financial services.

A similar deal was more recently finalized with California-based GreenBox POS, LLC, whereby MTRAC will serve as a strategic sales and marketing resource to help nurture GeenBox’s advanced POS (point of sale) software and technology out of beta and into the market (http://cnw.fm/Df7yl). MTRAC CEO Vanessa Luna commented on the rich operational feature set of GreenBox’s POS platform, explaining that the “details, intricacies and overall effectiveness” of the technology is unrivaled by anything the company has seen before. Spanning everything from compliance, financial audit prep and expense tracking to tax payments and data fidelity controls, the sophistication of GreenBox’s software suite is rivaled only by its custom-built blockchain KIOSK solutions for cashless operations.

Compliance is Key

Having completed a joint-venture partnership agreement with compliance software and merchant payment solutions innovator Integrated Compliance Solutions, LLC, earlier this year, MTRAC is clearly pulling out all the stops to put together a robust de-risking solution for the retail cannabis space (http://cnw.fm/ITkO1). By leveraging the company’s core fintech competencies and a growing network of strategic partners, Global Payout is unifying the concepts of “seed to bank” and “banking the unbankable” in a compliance-centric fashion expected to appease even the most stringent of regulators. This is a move by the company that is commensurate with the maturation of the sector into a fully modern and respectable industry — an industry on the road to potentially becoming a $24 billion-plus nationwide market by 2025 and that now has the muscle of California, the nation’s highest gross domestic product state, firmly behind it (http://cnw.fm/3DnZi).

Why it’s Worth the Fight

With over 100 million Americans suffering from some form of chronic pain and over 2 million addicted to prescription pain killers such as opioids, the development of compliance-friendly solutions to legal cannabis financing by Global Payout could be akin to a lifesaving measure because of the drug’s reputation as a less dangerous pain relief alternative. The importance of seeking such solutions is addressed in a recent report by the National Academies of Sciences, Engineering, and Medicine Committee on “The Health Effects of Cannabis and Cannabinoids,” which noted that “evidence regarding the short- and long-term health effects of cannabis use remains elusive” despite myriad studies that have examined cannabis use in all its forms, and that “often these research conclusions are not appropriately synthesized, translated for, or communicated to policy makers, health care providers, state health officials, or other stakeholders who have been charged with influencing and enacting policies, procedures, and laws related to cannabis use.” (http://cnw.fm/2lCHx). Another data point of importance is North America’s dominance of the $5.5 billion chronic pain therapy market (http://cnw.fm/4NIfq), nearly $2 billion of which is represented by the top three Medicare opioids.

Expanding Retail Network

The execution of a sales partnership and commission agreement in early February with Eyechronic cannabis media network operator and award-winning retail technology company Eyeconic.tv will allow MTRAC to reach customers in-store at the nearly 300 medical and retail dispensaries in Eyechronic’s nationwide partner network (http://cnw.fm/4X9xd). Combined with the already sizeable network of dispensaries MTRAC has cultivated relationships with via its PotSaver brand publication, the Eyechronic deal will give Global Payout serious ground game in California.

Sales and Marketing Support

MTRAC is wasting no time capitalizing on this advantage. The company recently expanded the sales team for its PotSaver brand in order to extend its reach beyond the thriving San Diego market into the surrounding metro areas. This includes the massive Los Angeles market, where many dispensaries have already received their licenses. This expansion is shrewdly timed to fully enable the debut of the company’s premier LA publication, slated for the second quarter of 2018 (http://cnw.fm/eWy6K). The retail technology benefits of the Eyechronic deal will overlap nicely with the sales and marketing management agreement signed earlier this year with High Grade Management Group, Inc. The deal is designed to facilitate the launch of High Grade’s Apple Vapes line of products through a sophisticated marketing campaign (http://cnw.fm/If2VZ).

The concentrates that go into vape cartridges are the fastest-growing segment of the cannabis market, and vapes are the largest slice of the pie across the major state markets. Up 37.5 percent in Colorado last year alone, concentrates easily outpaced the 25 percent growth seen by edibles, raking in $131 million in that state alone (http://cnw.fm/S3n4X). As further evidence of the potential for MTRAC’s vapes deal with California marijuana delivery service Eaze tracked a whopping 400 percent growth rate for its vape cartridges from 2015 to 2016 (http://cnw.fm/oQZ0d).

A Wide Open Market

From payment solutions and vaporizer pens to multimedia and advertising, the sheer variety of heavily integrated verticals now present within the cannabis sector is dizzying. And Global Payout is by no means alone in its efforts to bring cannabis consumer solutions to market.

Although perhaps more often referenced as a cannabinoid R&D biotech company known for its industrial hemp and nutraceutical and pharmaceutical products, mCig, Inc. (OTCQB: MCIG) has made significant strides of late via the company’s Obitx, Inc. (OBITX) subsidiary, to become a leader in digital advertising and marketing for the cannabis industry (http://cnw.fm/xCl85). The recent announcement of an S-1 registration, with the intent to spin off subsidiary Obitx into its own separate public company, marks a major milestone for this heavily diversified sector operator. The company’s announcement in late January (http://cnw.fm/1tKqt) that mCig will expand beyond its already full spectrum of hemp CBD skin products into CBD-based pet wellness products that directly address the $110 billion global pet care market (http://cnw.fm/ZsaJ3) provides further evidence of its diversification.

Another heavy hitter in cannabis sector digital media is the increasingly vertically integrated Freedom Leaf, Inc. (OTCQB: FRLF), which has established itself as a leading go-to resource for news and information via the company’s flagship publication, Freedom Leaf Magazine (http://cnw.fm/0wuI9). Freedom Leaf has also made strides of late to leverage the company’s considerable business consulting, as well as M&A expertise, in order to branch out further into the product end of the market. The company’s recent joint venture supply agreement with NutraFuels, Inc. (OTC: NTFU), whereby Freedom Leaf will assist in the formulation, blending and private labeling of NutraFuels’ Ayurvedic Breathable Vapor Oils, is a hallmark of this trend (http://cnw.fm/1QiSd). In support of this move, the company also fully acquired the Spanish hemp products producer Green Market Europe S.L., in January (http://cnw.fm/hQHO6). Green Market has indoor facilities totaling over 64,000 square feet and over 200 acres of outdoor production space.

Widely known in the industry for its packaging, supplies and accessories, Kush Bottles, Inc. (OTCQB: KSHB) recently announced a $6 million investment from private equity fund Merida Capital Partners, which will help the company reach out into new distribution channels and invest in new products (http://cnw.fm/1pKoE). This announcement followed fast on the heels of a sweeping Future Farm Technologies, Inc. (OTC: FFRMF) deal, which has Kush Bottles supporting Future Farm’s expansion into new cannabis and hemp territories such as California, Massachusetts, Maine, Florida and Puerto Rico (http://cnw.fm/s9PLf). Kush was selected by Future Farm because of the company’s superb reputation for high-quality cannabis packaging and branding, as well as tailored compliance solutions.

Branching out in a different way, Solis Tek, Inc. (OTCQB: SLTK) represents another key vertical of the matured cannabis market — one that is at the heart of the entire industry: growing hardware. As Kevin Kuethe, COO of cultivator and biopharma R&D powerhouse GB Sciences recently put it, GB’s “heaviest yields to date” can be chalked up in part to the ability of the Solis Tek fixtures and lights to deliver a hearty “diet of light” that closely mimics sunlight (http://cnw.fm/jE12T). For GB Sciences, which is geared towards standardized cultivation and consistent quality, Solis Tek’s focus on science sets the company’s hardware apart from the competition. Consistent quality and high yields are the name of the game for many cultivators, and dominating this essential vertical is SLTK’s specialty.

Diversity Comes of Age

It is evident that more and more sector operators are looking to diversify into complementary, upward parallels. And while the advanced payment solutions developed by a company such as Global Payout might be the low-hanging fruit due largely to the need to overcome banking regulatory compliance hurdles, it is the growing diversity of this truly modern industry that should instill investors with confidence in its future.

For more information on Global Payout, Inc., visit Global Payout, Inc. (GOHE).

About CannabisNewsWire

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

Skinvisible, Inc. (SKVI) Aims to Increase Shareholder Value through Proposed Deal with Quoin

Drug delivery platform ideal for M&A-driven growth
$80 billion global dermatology market
$30 billion global over-the-counter skincare market
Half of the 100 million surgeries performed in the U.S. require post-surgical pain medication, according to Transparency Market Research report

If history repeats itself, as we are often told, then Skinvisible, Inc.’s (OTCQB: SKVI) proposed deal with Quoin Pharmaceuticals Limited (“Quoin”) could increase shareholder value after execution. In late 2017, the company announced its plan to merge with Quoin, a marriage made in heaven that combines Skinvisible’s virtues as a drug delivery developer with Quoin’s position as a producer of post-surgical pain products that replace or diminish opioid use (http://cnw.fm/Fi2E7). Over the past two decades, mergers in the pharmaceutical industry have generally resulted in positive returns to shareholders, and today’s market leaders are the ones that have been most active in mergers and acquisitions.

There are many reasons why a merger may make sense. Taking over a rival, for example, means acquiring that rival’s market share and most, if not all, of its revenues. If product lines or business divisions overlap, costs can be cut and synergies exploited. In addition, purchasing a rival or merging with one may mean the acquisition of exciting new products at a much-reduced cost. It may cost the acquirer less to buy the target (and its product line) than to attempt to develop similar products in-house. Also, borrowing costs matter. If interest rates are low and likely to rise, now might be the time to borrow and spend. These are all good rationales for corporate consolidations. However, ‘growth is the main driver for most M&A deals: not just growth in drug distribution scale or earnings growth through cost cutting, but in revenues—and especially share price’, according to McKinsey & Company (http://cnw.fm/6WkAw).

Skinvisible is ideally poised to grow by acquisition, since its core business revolves around a drug delivery methodology that’s applicable to a wide range of topical products. Such ‘platform companies’ have a bright future, since they are enablers rather than competitors to other drug companies. Hedge fund manager Bill Ackman, the founder of Pershing Square Capital Management, opined, ‘“platform companies”—those that grow through bolt-on acquisitions—enrich their shareholders with each new deal…’ (http://cnw.fm/M9tG1). If that is to be believed, there’s little doubt that Skinvisible is treading the right path.

Since 1999, pharmaceutical and cosmeceutical companies have been adopting Skinvisible’s Invisicare® technology, developed through wholly-owned subsidiary Skinvisible Pharmaceuticals, Inc. The technology can be used to revitalize or create new medical or skincare products, allowing a company that licenses Skinvisible’s formulations to sell its own patented product and combat generic competitors.

Products utilizing Invisicare have been effective at bonding active ingredients to the skin for up to four hours and longer. Invisicare is non-occlusive; it allows normal skin respiration and perspiration while moisturizing and protecting against exposure from a wide variety of environmental irritants. When topically applied, products formulated with Invisicare adhere to the skin’s outer layers, forming a protective bond, resisting wash-off and delivering targeted levels of therapeutic or cosmetic skincare agents to the skin. This allows enhanced delivery performance for a variety of topicals resulting in improved efficacy, longer duration of action, reduced irritation and lower dosage of active agents required. The ‘invisible’ polymer compositions that make up Invisicare wear off as part of the natural exfoliation process that removes the skin’s outer layer of cells.

With a $80 billion global dermatology market and a $30 billion global over-the-counter skincare market, the patented polymer delivery system for topical products developed by Skinvisible has a great deal of potential to add shareholder value.

For more information, visit the company’s website at www.Skinvisible.com

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Pressure BioSciences Inc. (PBIO) Agreement with ISS, Inc. Shows Potential to Enhance Drug Discovery and Development

The two companies entered co-marketing and distribution agreement to be implemented worldwide
Pressure BioSciences’ high pressure generator technology can improve optical spectroscopy accuracy and data collection with potentially far-reaching impact on drug development
The joint technology will be promoted to scientists all over the world and is expected to generate increased sales starting this year

A leading developer and provider of innovative high pressure-based solutions to the global life sciences industry, Pressure BioSciences, Inc. (OTCQB: PBIO) has entered a two-year agreement with ISS, Inc., a prominent designer and manufacturer of advanced scientific instruments with more than 30 years of experience in the field. Under the agreement, the two companies will join their marketing and distribution efforts worldwide, as well as their own technologies to create an advanced high pressure optical spectroscopy system that’s expected to generate significant data that could be critical to the discovery and development of new biopharmaceutical diagnostics and drugs, according to a Pressure BioSciences press release issued on February 14, 2018 (http://cnw.fm/PdX88).

Optical spectroscopy is typically used by scientists all over the world as a powerful analytical method to generate and gather information about the composition of biological molecules. The collected data have multiple applications ranging from the design of new drugs to the development of preventive strategies against certain diseases. However, with high pressure optical spectroscopy, scientists have access to a more unique and effective way to study molecular interactions instantaneously and with a better control of reversibility and irreversibility, due to the easily adjustable duration and amount of applied pressure. This can greatly improve the speed and accuracy of data collection, helping scientists better understand how biological molecules function and interact, with a significant impact on the discovery and development of improved drugs and diagnostics.

ISS is confident that, by using Pressure BioSciences’ patented and game-changing pressure cycling technology (“PCT”) with its optical cell systems instead of current manual pressure generators, scientists will be able to “visualize biochemical reactions as they are happening in the pressure cell,” as noted by ISS President Dr. Ben Barbieri in a news release. “The Pressure BioSciences pressure generators will also facilitate automated and significantly faster data collection. Such systems could potentially have a significant and far-reaching impact on drug development and other important areas of biomedical research worldwide,” he added.

“This powerful combination of technologies will be promoted to scientists worldwide by both Pressure BioSciences and ISS, with the combined system expected to drive an increase in sales this year and beyond,” commented Dr. Nate Lawrence, PBIO VP of Marketing and Sales.

The ISS Agreement is the latest in a series of acquisitions and collaborations that Pressure BioSciences has entered into over the last few months, including, most notably, the acquisition of BaroFold, Inc.’s assets in December of last year and its entry into a strategic partnership with Phasex Corporation in October 2017. The BaroFold acquisition has significantly increased the company’s intellectual property estate by eight issued patents and several others that are pending, as noted by CEO Richard T. Schumacher on a ‘Stock Day’ podcast (http://cnw.fm/JBO5o).

With Phasex, the collaboration has allowed Pressure BioSciences to enter the fast-growing nanoemulsions market, where its proprietary PCT-based Ultra Shear Technology can be used with Phasex’s Supercritical Fluid processing to generate water-soluble, fully stable nanoemulsions. Ensuring stability of nanoemulsions has been a challenge until now, but this strategic collaboration has every chance to change that, leading to the further expansion of an already large market and an increase in the number of potential nanoemulsion applications in industries ranging from pharmaceuticals, nutraceuticals, cosmetics, paints and industrial lubricants to food and even medical cannabis (e.g., CBD).

Unlike most commercially-available emulsions, which tend to be unstable and sometimes inappropriate for human use due to a high amount of surfactants required, nanoemulsions have been shown to improve absorption, enhance stability, exhibit higher bioavailability, contain reduced amounts of surfactants and present multiple other advantages. Pressure BioSciences is confident that, with its patented Ultra Shear Technology, it will be able to develop commercial-scale nanoemulsions that require less emulsifying events, or even none at all.

For more information, visit the company’s website at www.PressureBioSciences.com

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Medical Cannabis Payment Solutions (REFG) Helps Fill State Coffers

States that legalize medical cannabis reaping large tax windfalls
State-sanctioned cannabis businesses forced into cash-only operation due to federal banking impasse
REFG resolves cannabis banking and operational issues, generating more state tax revenues

Current regulatory anxiety surrounding cannabis will have little impact on the long-term growth of the industry. Evermore states continue to relax marijuana strictures not only in response to citizen demand but also to generate tax revenues. There’s overwhelming scientific evidence validating the medical efficacy of certain cannabinoids, and states that have legalized marijuana in various forms are finding that cannabis cash is filling state coffers. In 2016, marijuana tax revenue totaled $256 million in Washington and $60 million in Oregon. Meanwhile, Colorado has harvested over half a billion dollars in taxes and fees since it legalized recreational weed. In a report from New Frontier Data highlighted in Forbes (http://cnw.fm/0ioNa), tax revenues in states with legalized marijuana were estimated at $1.8 billion last year. States are addicted to cannabis tax revenues and more states will look to legalization to increase income.

The states’ need and subsequent reliance on marijuana tax revenues pits state rights against federal oversight. This ongoing impasse has created a banking conundrum and an enormous opportunity for Medical Cannabis Payment Solutions (OTC: REFG). Banks are licensed and regulated by the federal government and, subsequently, are reluctant to accept proceeds from any marijuana operation. Medical Cannabis Payment Solutions delivers solutions to state-sanctioned medical cannabis operations, providing end-to-end management across multiple management systems. REFG resolves all the fragmentation issues created by the federal government impasse and rapid industry growth.

REFG delivers an industry first, secure, state-of-the-art financial services system that’s simple to set up and easy to use. The company’s purpose-built solution to cannabis banking solves cash handling issues, offers electronic payment and e-commerce features and gives marijuana businesses immediate access to funds while keeping them in compliance with all federal (FinCEN) laws aimed at combatting domestic and international money laundering, terrorist financing and other financial crimes. Not only compliant, REFG’s end-to-end payment processing solution finally provides cannabis customers and retailers with payment options other than cash.

REFG’s proprietary ‘StateSourced” closed-loop merchant processing system is the first operation of its kind geared to the legal cannabis industry. Not a prepaid or gift card, it is one of the first and only comprehensive card processing operations to break the operational and logistical logjam caused by cash-only transactions in state-sanctioned marijuana businesses. The debit card from Medical Cannabis Payment Solutions can only be used for payment within a state where marijuana is legal and only for cannabis-related products from state-sanctioned vendors. Businesses using the company’s card realize an immediate advantage in reducing risks, meeting regulatory requirements and improving customer interactions.

There’s no longer any doubt about the medical efficacy of certain cannabinoids. State-sanctioned delivery of these medications will not only continue but is likely to expand due to patient needs and the states’ increasing reliance on the massive influx of cannabis tax revenues.

For more information, visit the company’s website at www.MedicalCannabisPaymentSolutions.com

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Global Payout, Inc. (GOHE) Names Bill Rochfort as SecurCapital Corp. President and EVP Sales

James Hancock, CEO of Global Payout, lauds the SecurCloud Platform offered by company’s SecurCapital subsidiary
Rochfort announces SecurCapital’s participation in global fintech and blockchain conferences to demonstrate platform’s ranging capabilities
Key to SecurCapital’s performance is its disruptive ‘banking in a box’ cloud-based finance solutions platform

Global Payout, Inc. (OTC: GOHE) has named Bill Rochfort as the new president and EVP sales at SecurCapital Corp., its newly-formed subsidiary (http://cnw.fm/r8Ir8). SecurCapital Corp. is a supply chain finance company offering both working capital and premier payment solutions for the logistics industry. Its SecurCloud Platform offers an integrated solution for global payments through a proprietary ecosystem controlled by the client. As a result, the client can then optimize management of cash flow through delivery of documentation of invoices, proof of delivery and payments to global vendors.

SecurCapital CEO Steve Russell, prior to joining SecurCapital, was group CEO for an amalgamated rollup of eight logistics companies focused on targeting and managing M&A, integrating acquisitions, rebranding and positioning for exit. For four years, he was president and CEO, Asia Pacific, of Salesforce.com (NYSE: CRM), launching its platform in 12 Asia-Pacific countries.

SecurCapital has plans to attend a global schedule of fintech and blockchain conferences in China, the United Kingdom, and the U.S. (http://cnw.fm/d7OaC). Bill Rochfort champions the schedule as showing the global capability of the company’s web-enabled finance solutions platform. Rochfort is a 25-year veteran of the fintech industry in global banking, e-wallet platforms, freight payment and foreign exchange. He was an early utilizer of cloud technology. He previously served as an officer with companies such as Sprint, Intermedia and Premier Global Services.

In a news release, James Hancock, CEO of San Diego-based Global Payout, said, “We’re very excited to have Bill join our senior team of logisticians at SecurCapital at this pivotal time as the company launches its SecurCloud Platform (SCP)… Leveraging years of international finance experience, Bill will be instrumental in driving the SecurCapital value proposition to our customers.”

“Launching our platform throughout the world in Shanghai, London, San Francisco and Boston demonstrates our capability to offer our customer solutions on a global scale,” Rochfort said. He added that the upcoming events would bring together digital banking, blockchain, business lending, payments and insurance and smart contracts applications.

The company’s upcoming schedule includes: MIT FinTech on March 10-11 in Cambridge, Massachusetts; the Lendit FinTech Conference on April 9-11 in San Francisco, California; the Global FinTech & Blockchain Conference on April 12-13 in Shanghai, China; and the London FinTech World Forum on May 30-31 in London, England.

GOHE is a leading provider of comprehensive and customized prepaid payment solutions, distributing money worldwide for domestic and international companies. GOHE will offer its fintech payment system to many vertical markets for support of digital currency and foreign currency exchange. SecurCapital is marketed as a fully configurable ‘banking in a box’ cloud-based platform.

For more information, visit the company’s website at www.GlobalPayout.com

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) is “One to Watch”

Two applications for Health Canada ACMPR license in detailed review stage; one in the detailed review stage and one application in readiness stage
Canadian recreational market projected to surge to over $8 billion by 2021
Two growing facilities undergoing state-of-the-art retrofit have potential to generate CDN$16 million in revenue, excluding cannabis oils
Choom™ Retail Stores and Retail Store partner program to offer high-quality, premium branded retail cannabis dispensaries and the opportunity for individual investor store ownership across Canada

Choom Holdings Inc. (OTCQB: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

For more information, visit the company’s website at www.Choom.ca

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) is “One to Watch”

Vertically-integrated cannabis company with two late-stage ACMPR licenses in portfolio
Strategic investments focus on proven, revenue-generating cannabis-related businesses
Liberty Leaf is included in the Solactive Emerging Marijuana Growers Index

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) is a publicly traded Canadian-based company with strategic investments in businesses that are established, revenue- producing players in the medicinal and recreational cannabis market. Liberty Leaf’s focus is to build and support a diversified portfolio of cannabis-sector businesses, including those involved in the cultivation and processing of legal medicinal and recreational cannabis, value-added CBD/THC pet products, and supply-chain products for this dynamic and fast-growing sector. Liberty Leaf provides funding, management, HR resources and marketing expertise to help companies thrive and accelerate growth.

Liberty Leaf’s leading investments to date include:

North Road Ventures – An emerging end-to-end distributor of cultivated and manufactured cannabis products to licensed legal retailers. North Road has updated its application for an Access to Cannabis for Medical Purposes Regulations (ACMPR) license to be distribution/sales-focused, making the company unique in the crowded field of other cultivation-based applicants. This forward-thinking initiative will help fulfill the anticipated increase in Canada’s recreational cannabis space once legalization takes effect in mid-2018. The submission includes a boost in product-vault capacity that will result in a five-fold increase in products available for distribution. Cannabidiol (CBD)-oil products are expected to account for 50 percent or more of projected sales.
Just Kush Enterprises – Liberty Leaf holds a 60 percent interest in Just Kush, a cultivator of premium, proprietary cannabis strains selected for different levels of CBDs and THCs. Just Kush’s cultivation facility is located near Oliver, British Columbia, and it currently controls a facility which holds a Medical Marihuana Access Regulations (MMAR) license. The company is also a late-stage applicant for an ACMPR license (Access to Cannabis for Medical Purposes Regulations), which will enable Just Kush to produce cannabis for the medicinal and recreational market.

Liberty Leaf is also an active partner with the following companies:

ESEV R&D – A privately owned, medical marijuana research and development company based in New York with clinical laboratories located in Israel. ESEV R&D, in collaboration with a leading clinical research organization in Israel, has launched a one-of-a-kind service for North American medical cannabis companies to organize and oversee clinical trials seeking to demonstrate the efficacy of medical cannabis products for specific medical conditions. Liberty Leaf has a three-year collaborative agreement with ESEV. Under that agreement, ESEV is researching the efficacy of CBDs in pets, with the 1st formulation trial targeting canine osteoarthritis, a medical condition that includes: hip dysplasia; elbow dysplasia; and hind-knee, also known as stifle, degenerative joint disease (DJD).
Blox Labs Inc. – A boutique technology company focused on creating best-in-class smartphone apps and software solutions driven by emerging trends in blockchain, smart contracts and decentralized application technologies. Liberty Leaf and Blox Labs are developing “cannaBLOX,” a blockchain-based smart contract supply chain management platform for the legalized cannabis industry.

The company’s management team is led by President and Director William Rascan who has 25-plus years in the investment brokerage industry, most recently as a partner, senior investment advisor with Northern Securities. Rascan’s business experience ranges from active international trading clients to raising capital for junior mining companies on the TSX Venture Exchange.

Rascan is joined by CFO Jamie Robinson, a chartered accountant who specializes in accounting, auditing, and financial reporting under both IFRS and ASPE. Prior to joining Liberty Leaf, Robinson worked at Deloitte as a manager focused on publicly listed and private company audits, business review, performance enhancement engagements and restructuring proceedings.

Steven Feldman, who has more than 25 years of experience in the capital markets and was part of the original management team of SouthGobi Resources; and Doug Macdonell, a retired RCMP officer and recognized expert in the field of cannabis and cultivation, serve as company directors. Dr. Robert Jackman, who has worked closely with multiple clients in the medical cannabis and Natural and Non-prescription Health Products (NNHP) industries in North America, was recently appointed as scientific project manager/fulfillment.

Liberty Leaf’s advisory board includes international lawyer, writer and speaker Robert W.E. Laurie; Barinder Rasode, who currently serves as CEO of the National Institute for Cannabis Health & Education (NICHE); and Dr. Mary C. Fitzpatrick, B.S., D.V.M., whose primary focus is on helping companion animals live pain free in their senior years.

For more information, visit the company’s website at www.LibLeaf.ca

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Global Hemp Group Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Aims to be a Leader in the Multi-Faceted Industrial Hemp Market

Industrial hemp is the only commodity that has the potential to generate revenue from multiple finished goods in the global food, construction materials, nutraceutical, textile and bio-energy industries
Global Hemp Group completed hemp trials last year which set the stage for a full-fledged commercial hemp operation in New Brunswick, Canada, in 2018
Under Canadian law, CBD will become legal to extract from Industrial Hemp in July 2018
Hemp Business Journal estimates that the hemp industry will grow to $1.8 billion in sales by 2020, led by hemp food, body care, and CBD-based products
Official data demonstrates that the hemp industry is growing rapidly, at a 22 percent five-year CAGR, and is being led by food and body care products, with hemp CBD products showing a 53 percent AGR

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is just beginning to scratch the surface of what will over time become a robust market for the production of raw materials and a variety of wholesale products and consumer goods developed from the non-psychoactive industrial varieties of the species Cannabis sativa L.

Global Hemp Group intends to establish and develop a portfolio of companies interlinked in the production of hemp, from its initial cultivation to wholesale materials delivered to product developers and distributors.

Through joint ventures and acquisitions, GHG is focused on cannabinoid production, with medium-term plans to operate in the automotive, building materials, bio-composites, food, nutritional supplements and nutraceuticals markets. The company is guided by the overarching theme of ‘global environmental stewardship’. Global Hemp Group intends to apply key concepts of sustainability and social responsibility in all of the markets that it enters.

With a successful hemp cultivation trial last year, GHG and joint venture partner Marijuana Company of America, Inc. (OTC: MCOA) have set the stage for development of the first commercial hemp operation on the Acadian peninsula of New Brunswick, Canada, in over 20 years.

Cannabinoids

With the expected legalization of recreational cannabis and the extraction of cannabinoids from industrial hemp in mid to late 2018, the partnership expects to begin cannabinoid extraction from a minimum of 125 acres of hemp grown this year in New Brunswick, Canada. The company is also discussing partnerships for straw processing to create building materials following the October harvest this year, with a medium- to long-term plan of building permanent processing facilities by the fall of 2019.

GHG is also pursuing hemp cultivation and extraction opportunities in the U.S. Pacific Northwest, with the goal of operating in both the Canadian and United States hemp markets.

Industrial Solutions

GHG seeks to establish an operating strategy it refers to as the Hemp Agro-Industrial Zone (“HAIZ”) (http://cnw.fm/A4Iqr), which will be focused on building a platform of cooperation between farmers, labor, technology and capital across all industrial hemp sectors to create collective value for shareholders. All parts of the plant are to be utilized with the HAIZ concept, including the production of CBD and other cannabinoid-based wholesale products from the flowers and leaves, cottonized fibers from the straw, building materials from the hurd (woody core) and oils and cakes from the grain.

Construction

A number of companies have begun producing hempcrete blocks that deliver a durable product that retains thermal mass and has a low carbon footprint when it comes to energy usage (http://cnw.fm/Ch3uq). They could also potentially reduce building material costs by 50 percent or more when cultivated, processed and constructed on site. Hempcrete has thermal qualities that preserve optimal indoor temperatures year-round in a wide variety of regions and climates. In addition, it is mold free, pest free and fireproof.

A Washington state company is retrofitting homes with hemp;
A Colorado company completed the state’s first permitted “hempcrete” structure in October (http://cnw.fm/9C8qF);
This Asheville, North Carolina, hemp home is one of four hemp homes constructed in the state (http://cnw.fm/oTs06);
Israel’s first hemp house was built last March on Mount Carmel;
Canada’s JustBioFiber constructed a house on Vancouver Island using an interlocking Lego-like hemp block, and there are hundreds of hempcrete buildings across Canada;
In Britain, five hempcrete homes were built in 2017 alone;
France has been constructing buildings with hemp for decades;
South Africa has promoted this hemp home as Africa’s most sustainable building (http://cnw.fm/NYA1v).

Bio-Composites

There are more than 10 million cars on the road that use hemp bio-composites for door panels, dashboards, consoles, carpeting and even brake pads. Mercedes, BMW and Lotus have been using hemp in their vehicle construction for many years (http://cnw.fm/J3Qjd). Auto manufacturers find that hemp auto parts lower vehicle weight and therefore improve gas mileage. Glass fiber used to make the body of a Chevrolet Corvette could easily be replaced with hemp fiber and be stronger and more resilient. Henry Ford knew in the 1940s that natural bio-composites could replace heavier metals used in auto manufacturing (http://cnw.fm/FtJ0k) and be lighter and stronger than traditional materials.

In Conclusion

It has been proven that hemp can be a sustainable alternative for many traditional materials used throughout history.

Hemp is the only plant on Earth that can feed, clothe, house, fuel and medicate humanity. Hemp is potentially the most industrially usable biomass produced over the shortest growth cycle, utilizing the least amount of water, nutrients and pesticides, while sequestering the greatest level of carbon. It is one of the few plants on the planet that can be grown commercially almost anywhere in the world.

For more information, visit the company’s website at www.GlobalHempGroup.com

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP): IP Portfolio, Licensing and R&D are Keys to Growth in 2018

LXRP has global patents or patents-pending in more than 40 countries, including the U.S., Australia, China, the European Union and Canada
Company is working through a C$250,000 budget for an 18-month collaborative research agreement with the National Research Council
Licensing is a revenue generator, with LXRP offering to license its disruptive DehydraTECH™ technology in countries where it is patented or patent-pending

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is generating revenue and knowledge through both licensing of its IP portfolio and advancement of R&D projects. It already has patents and multiple patents-pending in more than 40 countries. It has received patent approvals in the U.S. and Australia for its DehydraTECH™ delivery technology (http://cnw.fm/WIdR3). Some patent applications have already reached the active patent investigation phase in China, the European Union and Canada.

LXRP is a technology disruptor for delivery of edible forms of cannabinoids. This Kelowna, British Columbia-based food bioscience company has developed a high absorption hemp oil formula, protein energy bars, exotic teas and coffee, beer and soft drinks, and capsules and mouth-melts. All of these products share qualities of high absorption and radically improved taste, as compared to other cannabis-related food products.

The Canadian Institutes of Health Research has secured $1.4 million in funding for Canadian cannabis research projects (http://cnw.fm/DeM9h). That will fund research ranging from the potential impacts of cannabis on driving, pregnancy, childhood health, youth mental health, indigenous populations and workplace health and safety (http://cnw.fm/gTE4r).

LXRP itself has signed a C$250,000 collaborative research agreement with the National Research Council (“NRC”) for an 18-month period to investigate opportunities and determine the best methods for processing lipophilic active agents within foods.

Licensing its intellectual property portfolio is a core revenue generation strategy for LXRP (http://cnw.fm/pmF79). For example, the company’s disruptive new DehydraTECH technology is available to be licensed in areas including processed foods, supplements, vitamins, drugs and cannabinoids. To prospective licensees, LXRP can eventually transition to a definitive fee for a structure agreement between itself and a new licensee.

The company makes its technology available on either a semi-exclusive or exclusive access basis that defines licensing by geographic region(s), for a set period of time and limited to specific product categories. LXRP has suggested that it will license DehydraTECH in any of the more than 40 countries globally where it is patented or patent-pending.

For more information, visit the company’s website at www.LexariaBioscience.com

More from CannabisNewsWire

About CannabisNewsWire

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net